Domitner GmbH placed initial order that is expected to ship in the third quarter of 2024
Combined with the German distribution announced in July, there is strong coverage in central Europe
Additional European distributors are expected to be secured in 2024
MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetes
Designed to be simpler and more affordable to expand access to diabetes technology for previously underserved communities
Commercial availability expected in early 2025
Click here to view interview video
Paramount near-term activities include planned October 2024 commercial launch of FDA-approved oral mucositis prescription product Gelclair® and results from independent, investigator-initiated trials of crofelemer for rare diseases
Read More